157 related articles for article (PubMed ID: 6291359)
1. Captopril in congestive heart failure: improved left ventricular function with decreased metabolic cost.
Chatterjee K; Rouleau JL; Parmley WW
Am Heart J; 1982 Nov; 104(5 Pt 2):1137-46. PubMed ID: 6291359
[TBL] [Abstract][Full Text] [Related]
2. Vasodilator therapy of severe congestive heart failure: the special importance of angiotensin-converting enzyme inhibition with captopril.
Awan NA; Mason DT
Am Heart J; 1982 Nov; 104(5 Pt 2):1127-36. PubMed ID: 6291358
[TBL] [Abstract][Full Text] [Related]
3. Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure.
Chatterjee K; Rouleau JL; Parmley WW
Br Heart J; 1982 Mar; 47(3):233-8. PubMed ID: 7037025
[TBL] [Abstract][Full Text] [Related]
4. Converting-enzyme inhibitor therapy for chronic heart failure.
Massie BM; Kramer BL; Topic N
Herz; 1983 Apr; 8(2):71-80. PubMed ID: 6343210
[TBL] [Abstract][Full Text] [Related]
5. Acute and long-term effects of captopril on left and right ventricular volumes and function in chronic heart failure.
Massie BM; Kramer BL; Topic N
Am Heart J; 1982 Nov; 104(5 Pt 2):1197-203. PubMed ID: 6291366
[TBL] [Abstract][Full Text] [Related]
6. Hemodynamic effects of captropril in chronic heart failure: efficacy of low-dose treatment and comparison with prazosin.
Sharpe DN; Coxon R
Am Heart J; 1982 Nov; 104(5 Pt 2):1164-71. PubMed ID: 6291361
[TBL] [Abstract][Full Text] [Related]
7. Variable clinical response to long-term angiotensin inhibition in severe heart failure: demonstration of additive benefits of alpha-receptor blockade.
Kugler J; Maskin CS; Frishman W; Sonnenblick EH; LeJemtel TH
Am Heart J; 1982 Nov; 104(5 Pt 2):1154-9. PubMed ID: 6127943
[TBL] [Abstract][Full Text] [Related]
8. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor.
Ader R; Chatterjee K; Ports T; Brundage B; Hiramatsu B; Parmley W
Circulation; 1980 May; 61(5):931-7. PubMed ID: 6244906
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic and metabolic effects of vasodilators, nitrates, hydralazine, prazosin and captopril in chronic ischemic heart failure.
Chatterjee K; Rouleau JL
Acta Med Scand Suppl; 1981; 651():295-303. PubMed ID: 7034478
[TBL] [Abstract][Full Text] [Related]
10. Contrasting hemodynamic responses in severe heart failure: comparison of captopril and other vasodilator drugs.
Packer M; Medina N; Yushak M
Am Heart J; 1982 Nov; 104(5 Pt 2):1215-23. PubMed ID: 6753552
[TBL] [Abstract][Full Text] [Related]
11. The effect of captopril on renal, coronary, and systemic hemodynamics in patients with severe congestive heart failure.
Powers ER; Bannerman KS; Stone J; Reison DS; Escala EL; Kalischer A; Weiss MB; Sciacca RR; Cannon PJ
Am Heart J; 1982 Nov; 104(5 Pt 2):1203-10. PubMed ID: 6753550
[TBL] [Abstract][Full Text] [Related]
12. Acute and long-term effects of captopril on exercise cardiac performance and exercise capacity in congestive heart failure.
Topic N; Kramer B; Massie B
Am Heart J; 1982 Nov; 104(5 Pt 2):1172-9. PubMed ID: 6291362
[TBL] [Abstract][Full Text] [Related]
13. Determinants of acute and long-term response to converting enzyme inhibitors in congestive heart failure.
Levine TB; Cohn JN
Am Heart J; 1982 Nov; 104(5 Pt 2):1159-64. PubMed ID: 6182784
[TBL] [Abstract][Full Text] [Related]
14. Coronary hemodynamic effects of angiotensin inhibition by captopril and teprotide in patients with congestive heart failure.
Halperin JL; Faxon DP; Creager MA; Bass TA; Melidossian CD; Gavras H; Ryan TJ
Am J Cardiol; 1982 Nov; 50(5):967-72. PubMed ID: 6182786
[TBL] [Abstract][Full Text] [Related]
15. Captopril pharmacokinetics and the acute hemodynamic and hormonal response in patients with severe chronic congestive heart failure.
Cody RJ; Covit A; Schaer G; Williams G
Am Heart J; 1982 Nov; 104(5 Pt 2):1180-3. PubMed ID: 6291363
[TBL] [Abstract][Full Text] [Related]
16. Complementary combined captopril and terbutaline therapy in severe chronic congestive heart failure.
Awan NA; Needham KE; Lui H; Rutledge J; Amsterdam EA; Mason DT
Am Heart J; 1982 Nov; 104(5 Pt 2):1224-8. PubMed ID: 6753553
[TBL] [Abstract][Full Text] [Related]
17. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril).
Kluger J; Cody RJ; Laragh JH
Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087
[TBL] [Abstract][Full Text] [Related]
18. [Clinical, haemodynamic and biochemical effects of angiotensin-converting enzyme inhibition in chronic refractory cardiac failure (author's transl)].
Kayanakis JG; Giraud P; Puel J; Cassagneau B; Sabot G; Fauvel JM; Bounhoure JP
Nouv Presse Med; 1981 Apr; 10(19):1583-6. PubMed ID: 6269558
[TBL] [Abstract][Full Text] [Related]
19. Determinants of clinical response and survival in patients with congestive heart failure treated with captopril.
Creager MA; Faxon DP; Halperin JL; Melidossian CD; McCabe CH; Schick EC; Ryan TJ
Am Heart J; 1982 Nov; 104(5 Pt 2):1147-54. PubMed ID: 6291360
[TBL] [Abstract][Full Text] [Related]
20. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
Rouleau JL; Chatterjee K; Benge W; Parmley WW; Hiramatsu B
Circulation; 1982 Apr; 65(4):671-8. PubMed ID: 7037220
[No Abstract] [Full Text] [Related]
[Next] [New Search]
